iPLATO Healthcare, a leader in mHealth, reported that the company had reached agreements to add 60 GP practices in two Primary Care Trusts in England to its mHealth platform. This will bring new mHealth services to another 300,000 people living in the South East of England. Underlining the attractiveness of the iPLATO service within the QIPP framework this follows a similar wave of adoption announced in September 2011.
"Since the summer we are connecting one new practice per day to our platform" says Tobias Alpsten, Managing Director of iPLATO Healthcare. "With these agreements in place we will see this growth continue at least until the end of the NHS financial year. Of course we have seen this level of growth before. However, things have changed in the NHS so this time around the growth is driven by QIPP and proven savings for primary care commissioning, public health and clinical commissioning groups from improved patient engagement. The population-wide approach to integrated mHealth that iPLATO champions has proven superior to the patchwork of services driven by individual surgeries, community services, hospitals and public health teams. More than anything these two wins validate that iPLATO mHealth is part of the solution to challenges faced by the NHS. We are delighted to add new mHealth innovation partners to our network."
Related news articles:
- iPLATO's Profile
About iPLATO
iPLATO Healthcare is an innovation company dedicated to mobile health since 2006. iPLATO’s evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions. Since August 2010 iPLATO Healthcare is listed on the National Framework for Telecare, Telehealth and Telecoaching products and services. Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile patient support services for people with diabetes, hypertension, epilepsy, COPD and HIV.